Document is current
Any future updates will be listed below
-
Authors
Stuart, Tim https://orcid.org/0000-0002-3044-0897
Hao, Stephanie
Zhang, Bingjie
Mekerishvili, Levan https://orcid.org/0000-0002-4792-5356
Landau, Dan A. https://orcid.org/0000-0003-2346-9541
Maniatis, Silas https://orcid.org/0000-0002-0888-1477
Satija, Rahul https://orcid.org/0000-0001-9448-8833
Raimondi, Ivan https://orcid.org/0000-0002-9522-2794
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (K99HG011489-01, RM1HG011014-01, RM1HG011014-01)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1HG011014-01)
- License Information
-
More Information
Article History
Received: 8 March 2022
Accepted: 24 October 2022
First Online: 19 December 2022
Competing interests
: In the past 3 years, R.S. has worked as a consultant for Bristol Myers Squibb, Regeneron and Kallyope and served as a Scientific Advisory Board member for ImmunAI, Resolve Biosciences, NanoString and the NYC Pandemic Response Lab. I.R. and S.M. have filed a patent application based on this work (US provisional application no. 63/276,533). The remaining authors declare no competing interests.
